Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations
The protections extend through at least 2035, with the potential for further extensions
The companies aim to expand treatment options for millions living with metabolic disorders
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Prithwish has close to 28 years of experience in a Commercial role
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
